Results 101 to 110 of about 27,148 (204)
High molar activity [11C]phosgene from [11C]CO2
Background [11C]Phosgene is a known but underutilised labelling synthon in PET-tracer development. The production of [11C]phosgene faces many problems such as difficulties in achieving high molar activity, regular key component replacement and complexity
Edla Kerminen +6 more
doaj +1 more source
A DPP6‐Targeted PET Tracer for Non‐Invasive Imaging of Transplanted Human Islets
ABSTRACT Introduction Dipeptidyl peptidase‐like protein 6 (DPP6) is a potential molecular imaging biomarker for pancreatic and transplanted islets of Langerhans. 4hD29 is a single‐domain antibody with nanomolar affinity for DPP6. Here, we demonstrate the generation and validation of [68Ga]Ga‐NOTA‐4hD29 for Positron Emission Tomography (PET) imaging of ...
Amina Khalil +11 more
wiley +1 more source
Background Lutetium-177 (177Lu) theranostics have revolutionized personalized cancer treatment, particularly with FDA-approved therapies like [177Lu]Lu-DOTA-TATE for neuroendocrine tumors and [177Lu]Lu-PSMA for prostate cancer.
William Hunt +9 more
doaj +1 more source
Summary Erysipelothrix rhusiopathiae was the causative agent of vegetative endocarditis and vertebral osteomyelitis in a 24‐year‐old Irish draught gelding that presented with prolonged history of intermittent pyrexia and tachycardia. Clinical investigations revealed persistently reduced neck mobility, tachydysrhythmia and episodic pyrexia up to 41°C ...
E. Kolovou +11 more
wiley +1 more source
ABSTRACT Introduction Radiosynoviorthesis (RSO) may alleviate pain and clinical symptoms in people with haemophilia (PwH), however, controlled longitudinal data on these outcomes remain limited. Aim To evaluate the effects of RSO on pain, joint health, swelling, and treatment satisfaction over twelve months. Methods Patients with an indication for RSO (
Alexander Schmidt +13 more
wiley +1 more source
Radiopharmaceutical transport in solid tumors via a 3-dimensional image-based spatiotemporal model
Lutetium-177 prostate-specific membrane antigen (177Lu-PSMA)-targeted radiopharmaceutical therapy is a clinically approved treatment for patients with metastatic castration-resistant prostate cancer (mCRPC).
Anahita Piranfar +6 more
doaj +1 more source
Impact of dose reduction and multi‐parametric harmonization on multi‐organ radiomics robustness in total‐body PET imaging: Methodological implications for quantitative theranostics [PDF]
Abstract Background Radiomic features derived from positron emission tomography (PET) are sensitive to count statistics and acquisition protocol variability, thereby limiting quantitative reliability in low‐dose and multi‐center total‐body PET imaging.
Azimi M, Cheraghi M, Zaidi H.
europepmc +2 more sources
Eccentric Occlusal Loads Remodel the Dentoalveolar and Temporomandibular Biomechanical Unit in Rats
Eccentric occlusal loads remodel the dentoalveolar and temporomandibular joints in the masticatory biomechanical unit in rats. (A) Bite block as an occlusal rise (OR) on the rat maxillary first molar (green region) is shown. (B) 18F‐NaF Positron emission tomography localised regions of higher metabolic activity (higher uptake in the left condyle ...
Haochen Ci +14 more
wiley +1 more source
Cancer stem cells (CSCs) are a dynamic population of tumor cells characterized by long-term self-renewal, high tumorigenicity, resistance to conventional therapies such as radio- and chemotherapy, and capacity to recapitulate the tumor heterogeneity ...
Tihomir Zh. Todorov +3 more
doaj +1 more source

